{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T01:28:15Z","timestamp":1784078895340,"version":"3.55.0"},"reference-count":51,"publisher":"MDPI AG","issue":"15","license":[{"start":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T00:00:00Z","timestamp":1753228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Institute of Theoretical and Experimental Biophysics","award":["075-00223-25-03"],"award-info":[{"award-number":["075-00223-25-03"]}]},{"name":"Medical Emulsions LLC.","award":["075-00223-25-03"],"award-info":[{"award-number":["075-00223-25-03"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>Poloxamer 188 is a polymer that is used as a carrier and stabilizer of pharmacological agents. It has been demonstrated to enhance red blood cell and hemoglobin levels in healthy animals and in select clinical cases. The objective of this study was to assess the efficacy of Poloxamer 188 in CBA mice when administered repeatedly in the carboplatin-induced myelosuppression model. The mice were administered carboplatin once at a dose of 100 mg\/kg, and then Poloxamer 188 was orally administered daily at doses of 10 mg\/kg, 100 mg\/kg, 500 mg\/kg, and 1000 mg\/kg for 7 and 21 days. Poloxamer 188 at a dose of 1000 mg\/kg was found to bring the level of 2,3-bisphosphoglycerate in red blood cells close to control level (p = 0.1331 for the control group compared to Poloxamer at a dose 1000 mg\/kg) already from day 8 of the study and in bone marrow resulted in regulation of genes responsible for hematopoiesis. G-GSF at day 8 and TNF\u03b1 at day 22 gene expression was significantly decreased by 54% (p = 0.012) and 16% (p = 0.024), respectively, with Poloxamer 188 administration at a dose of 100 mg\/kg. Additionally, in the bone marrow, the treatment was seen to exert a positive regulatory effect on the genes responsible for hematopoiesis. These findings are consistent with the observed increase in red blood cell by 6.7% (p = 0.001), hemoglobin by 4.7% (p = 0.0053), and reticulocyte percentage by 53.6% (p &lt; 0.0001) following Poloxamer 188 administration at a dose of 1000 mg\/kg in CBA mice with myelosuppression.<\/jats:p>","DOI":"10.3390\/ijms26157081","type":"journal-article","created":{"date-parts":[[2025,7,23]],"date-time":"2025-07-23T10:49:17Z","timestamp":1753267757000},"page":"7081","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Efficacy of Poloxamer 188 in Experimental Myelosuppression Model Induced by Carboplatin in CBA Mice"],"prefix":"10.3390","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0009-0003-0341-8955","authenticated-orcid":false,"given":"Arina V.","family":"Kholina","sequence":"first","affiliation":[{"name":"Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2320-655X","authenticated-orcid":false,"given":"Natalya A.","family":"Borozdina","sequence":"additional","affiliation":[{"name":"Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2989-4477","authenticated-orcid":false,"given":"Victor A.","family":"Palikov","sequence":"additional","affiliation":[{"name":"Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeniy S.","family":"Mikhaylov","sequence":"additional","affiliation":[{"name":"Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina N.","family":"Kravchenko","sequence":"additional","affiliation":[{"name":"Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata A.","family":"Dalevich","sequence":"additional","affiliation":[{"name":"Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina A.","family":"Pakhomova","sequence":"additional","affiliation":[{"name":"Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina N.","family":"Kazakova","sequence":"additional","affiliation":[{"name":"Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2547-8804","authenticated-orcid":false,"given":"Maria A.","family":"Timchenko","sequence":"additional","affiliation":[{"name":"Institute of Theoretical and Experimental Biophysics (RAS), Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0629-4014","authenticated-orcid":false,"given":"Alexander Ye.","family":"Yegorov","sequence":"additional","affiliation":[{"name":"Institute of Theoretical and Experimental Biophysics (RAS), Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maxim V.","family":"Molchanov","sequence":"additional","affiliation":[{"name":"Institute of Theoretical and Experimental Biophysics (RAS), Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7810-0675","authenticated-orcid":false,"given":"Artem M.","family":"Ermakov","sequence":"additional","affiliation":[{"name":"Institute of Theoretical and Experimental Biophysics (RAS), Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3311-8745","authenticated-orcid":false,"given":"Olga Y.","family":"Antonova","sequence":"additional","affiliation":[{"name":"Institute of Theoretical and Experimental Biophysics (RAS), Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1758-907X","authenticated-orcid":false,"given":"Olga Y.","family":"Kochetkova","sequence":"additional","affiliation":[{"name":"Institute of Theoretical and Experimental Biophysics (RAS), Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia M.","family":"Pankratova","sequence":"additional","affiliation":[{"name":"Institute of Mathematical Problems of Biology (RAS)\u2014The Branch of Keldysh Institute of Applied Mathematics of Russian Academy of Sciences, Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1503-0961","authenticated-orcid":false,"given":"Anton N.","family":"Pankratov","sequence":"additional","affiliation":[{"name":"Institute of Mathematical Problems of Biology (RAS)\u2014The Branch of Keldysh Institute of Applied Mathematics of Russian Academy of Sciences, Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena V.","family":"Arshintseva","sequence":"additional","affiliation":[{"name":"Medical Emulsions LLC, Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergey Y.","family":"Pushkin","sequence":"additional","affiliation":[{"name":"Medical Emulsions LLC, Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3053-2804","authenticated-orcid":false,"given":"Igor A.","family":"Dyachenko","sequence":"additional","affiliation":[{"name":"Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arkadiy N.","family":"Murashev","sequence":"additional","affiliation":[{"name":"Branch of the Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Pushchino 142290, Russia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,23]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/00002018-200326100-00003","article-title":"Drug-induced myelosuppression: Diagnosis and management","volume":"26","author":"Carey","year":"2003","journal-title":"Drug Saf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"3881","DOI":"10.2217\/fon-2022-0754","article-title":"Burden of chemotherapy-induced myelosuppression among patients with ES-SCLC in US community oncology settings","volume":"18","author":"Goldschmidt","year":"2022","journal-title":"Future Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1182\/blood-2019-126650","article-title":"Neutropenia in Myelosuppressed Cancer Patients Treated with Recombinant Human Erythropoietin (EPO)","volume":"134","author":"Wright","year":"2019","journal-title":"Blood"},{"key":"ref_4","unstructured":"Moore, C.A., and Krishnan, K. (2023). Aplastic Anemia, StatPearls [Internet]."},{"key":"ref_5","unstructured":"Mikhailov, E.S., Murashev, A.N., Bondarenko, D.A., Arshintseva, E.V., Dalewicz, R.A., Pushkin, S.Y., Pushkina, K.V., and Salykin, V.V. (2023, January 9\u201313). Study of the effectiveness of a drug stimulating hair growth in C57BL\/6 mice. Proceedings of the 26th Pushchino School-Conference of Young Scientists with International Participation \u201cBIOLOGY\u2014SCIENCE OF THE 21ST CENTURY\u201d, Pushchino, Russia. (In Russian)."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"799","DOI":"10.2174\/1570159X19666210528155801","article-title":"Poloxamer 188 (P188), A Potential Polymeric Protective Agent for Central Nervous System Disorders: A Systematic Review","volume":"20","author":"Chen","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"ref_7","first-page":"288","article-title":"Comparative study of the maximum tolerant dose of perfluoroorganic emulsions","volume":"3","author":"Arshintseva","year":"2022","journal-title":"Nauchnyy Asp."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"43","DOI":"10.24884\/2078-5658-2023-20-6-43-51","article-title":"Influence of perfluoroorganic emulsion on morphometric parameters of the liver in a systemic inflammatory response (experimental study)","volume":"20","author":"Ziamko","year":"2023","journal-title":"Messenger Anesthesiol. Resusc."},{"key":"ref_9","unstructured":"BASF (2024). Technical Information. Kolliphor\u00ae P 188 Bio. Kolliphor\u00ae P 188 Cell Culture. Poloxamer for Pharmaceutical & Biopharmaceutical Use, BASF."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.tem.2012.10.007","article-title":"Erythropoietin in cancer: A dilemma in risk therapy","volume":"24","author":"Cao","year":"2013","journal-title":"Trends Endocrinol. Metab."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/j.leukres.2012.04.017","article-title":"Erythropoietin: The swinging pendulum","volume":"36","author":"Oster","year":"2012","journal-title":"Leuk. Res."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1158\/1078-0432.CCR-10-2577","article-title":"The role of erythropoietin and erythropoiesis-stimulating agents in tumor progression","volume":"17","author":"Hedley","year":"2011","journal-title":"Clin. Cancer Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1055\/s-0032-1328893","article-title":"A review of safety, efficacy, and utilization of erythropoietin, darbepoetin, and peginesatide for patients with cancer or chronic kidney disease: A report from the Southern Network on Adverse Reactions (SONAR)","volume":"38","author":"Bennett","year":"2012","journal-title":"Semin. Thromb. Hemost."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1001\/jama.2021.3399","article-title":"Poloxamer 188 for Sickle Cell Disease","volume":"325","author":"Zylke","year":"2021","journal-title":"JAMA"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1345\/aph.1D223","article-title":"Purified poloxamer 188 for sickle cell vaso-occlusive crisis","volume":"38","author":"Gibbs","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jha2.343","article-title":"Degradation of red blood cell deformability during cold storage in blood bags","volume":"3","author":"Islamzada","year":"2021","journal-title":"eJHaem"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"e2219885120","DOI":"10.1073\/pnas.2219885120","article-title":"Consequences of poly(ethylene oxide) and poloxamer P188 on transcription in healthy and stressed myoblasts","volume":"120","author":"Crabtree","year":"2023","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1111\/j.1537-2995.2009.02303.x","article-title":"Stroma-free mass production of clinical-grade red blood cells (RBCs) by using poloxamer 188 as an RBC survival enhancer","volume":"49","author":"Baek","year":"2009","journal-title":"Transfusion"},{"key":"ref_19","unstructured":"BASF (2020). NA Product Regulations. Safety Data Sheet P188\u00ae P 188 Geismar, BASF."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"152437","DOI":"10.1016\/j.tox.2020.152437","article-title":"Poloxamer 188-mediated anti-inflammatory effect rescues cognitive deficits in paraquat and maneb-induced mouse model of Parkinson\u2019s disease","volume":"436","author":"Ding","year":"2020","journal-title":"Toxicology"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1097\/00001756-200401190-00033","article-title":"The surfactant poloxamer-188 protects against glutamate toxicity in the rat brain","volume":"15","author":"Frim","year":"2004","journal-title":"NeuroReport"},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Gu, J.H., Ge, J.B., Li, M., Xu, H.D., Wu, F., and Qin, Z.H. (2013). Poloxamer 188 protects neurons against ischemia\/reperfusion injury through preserving integrity of cell membranes and blood brain barrier. PLoS ONE, 8.","DOI":"10.1371\/journal.pone.0061641"},{"key":"ref_23","unstructured":"Arshintseva, E.V., and Pushkin, S.Y. (2021). New Application of Poloxamer as a Pharmacologically Active Substance. (Patent RUS NO. 2760324)."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"104153","DOI":"10.1016\/j.exphem.2024.104153","article-title":"Metabolic regulation of erythrocyte development and disorders","volume":"131","author":"Lyu","year":"2024","journal-title":"Exp. Hematol."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12185-024-03715-1","article-title":"Aplastic anemia: History and recent developments in diagnosis and treatment","volume":"119","author":"Onishi","year":"2024","journal-title":"Int. J. Hematol."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1007\/s11033-022-07311-6","article-title":"Carica papaya ameliorates thrombocytopenia through upregulation of Interleukin-11 and modulation of thrombopoietin in mouse model of carboplatin-induced myelosuppression","volume":"49","author":"Irshad","year":"2022","journal-title":"Mol. Biol. Rep."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1111\/vco.12622","article-title":"Carboplatin-induced myelosuppression as related to body weight in dogs","volume":"18","author":"Coffee","year":"2020","journal-title":"Vet. Comp. Oncol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00280-007-0582-9","article-title":"Pharmacodynamic model for chemotherapy-induced anemia in rats","volume":"62","author":"Woo","year":"2008","journal-title":"Cancer Chemother. Pharmacol."},{"key":"ref_29","first-page":"101","article-title":"Reduction in carboplatin hematopoietic toxicity in tumor bearing mice: Comparative mechanisms and effects of interleukin-1 beta and corticosteroids","volume":"12","author":"Rinehart","year":"1997","journal-title":"Cancer Biother. Radiopharm."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/psp4.12459","article-title":"Quantifying Drug-Induced Bone Marrow Toxicity Using a Novel Haematopoiesis Systems Pharmacology Model","volume":"8","author":"Fornari","year":"2019","journal-title":"CPT Pharmacomet. Syst. Pharmacol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"10020","DOI":"10.1002\/cam4.5738","article-title":"Burden of chemotherapy-induced myelosuppression among patients with extensive-stage small cell lung cancer: A retrospective study from community oncology practices","volume":"12","author":"Hart","year":"2023","journal-title":"Cancer Med."},{"key":"ref_32","unstructured":"Richardson, S.R., and O\u2019Malley, G.F. (2022). Glucose-6-Phosphate Dehydrogenase Deficiency, StatPearls [Internet]."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.4103\/1319-2442.121271","article-title":"The role of erythrocyte enzyme glucose-6-phosphate dehydrogenase (G6PD) deficiency in the pathogenesis of anemia in patients on hemodialysis","volume":"24","author":"Ali","year":"2013","journal-title":"Saudi J. Kidney Dis. Transplant."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.enzmictec.2006.06.017","article-title":"New combined kinetic and thermodynamic approach to model glucose-6-phosphate dehydrogenase activity and stability","volume":"40","author":"Hasmann","year":"2007","journal-title":"Enzym. Microb. Technol."},{"key":"ref_35","unstructured":"Patel, S., Jose, A., and Mohiuddin, S.S. (2023). Physiology, Oxygen Transport and Carbon Dioxide Dissociation Curve, StatPearls [Internet]."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Skverchinskaya, E., Levdarovich, N., Ivanov, A., Mindukshev, I., and Bukatin, A. (2023). Anticancer Drugs Paclitaxel, Carboplatin, Doxorubicin, and Cyclophosphamide Alter the Biophysical Characteristics of Red Blood Cells, In Vitro. Biology, 12.","DOI":"10.3390\/biology12020230"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1107\/S2059798322001802","article-title":"Molecular insight into 2-phosphoglycolate activation of the phosphatase activity of bisphosphoglycerate mutase","volume":"78","author":"Aljahdali","year":"2022","journal-title":"Acta Crystallogr. D Struct. Biol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.phoj.2024.02.003","article-title":"Red cell membranopathies: Case series and review of literature","volume":"9","author":"Sharma","year":"2024","journal-title":"Pediatr. Hematol. Oncol. J."},{"key":"ref_39","unstructured":"Hillyer, C.D., Silberstein, L.E., Ness, P.M., Anderson, K.C., and Roback, J.D. (2007). Blood Banking and Transfusion Medicine, Churchill Livingstone. [2nd ed.]."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.htct.2018.01.009","article-title":"THPO gene variants in patients with acquired aplastic anemia","volume":"40","author":"Padilha","year":"2018","journal-title":"Hematol. Transfus. Cell Ther."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s12185-013-1352-6","article-title":"Pathophysiology and management of thrombocytopenia in bone marrow failure: Possible clinical applications of TPO receptor agonists in aplastic anemia and myelodysplastic syndromes","volume":"98","author":"Townsley","year":"2013","journal-title":"Int. J. Hematol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1182\/blood.V92.1.4.413k38_4_10","article-title":"Role of c-mpl in early hematopoiesis","volume":"92","author":"Solar","year":"1998","journal-title":"Blood"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"133","DOI":"10.4103\/0973-1296.80671","article-title":"Protective effects on myelosuppression mice treated by three different classic Chinese medicine formulae","volume":"7","author":"Zhao","year":"2011","journal-title":"Pharmacogn. Mag."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1182\/blood-2016-11-752923","article-title":"Granulocyte colony-stimulating factor mobilizes dormant hematopoietic stem cells without proliferation in mice","volume":"129","author":"Bernitz","year":"2017","journal-title":"Blood"},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"106341","DOI":"10.1016\/j.isci.2023.106341","article-title":"Temporal dynamics of TNF-mediated changes in hematopoietic stem cell function and recovery","volume":"26","author":"Hidalgo","year":"2023","journal-title":"iScience"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1182\/blood-2003-01-0114","article-title":"TNF-\u03b1 and IFN-\u03b3 are overexpressed in the bone marrow of Fanconi anemia patients and TNF-\u03b1 suppresses erythropoiesis in vitro","volume":"102","author":"Dufour","year":"2003","journal-title":"Blood"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.immuni.2013.02.007","article-title":"Tumor necrosis factor-\u03b1 blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation","volume":"38","author":"Kanterman","year":"2013","journal-title":"Immunity"},{"key":"ref_48","first-page":"96","article-title":"Practical murine hematopathology: A comparative review and implications for research","volume":"65","author":"Mikkola","year":"2015","journal-title":"Comp. Med."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1007\/s10875-012-9844-3","article-title":"Critical differences in hematopoiesis and lymphoid development between humans and mice","volume":"33","author":"Parekh","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"ref_50","doi-asserted-by":"crossref","unstructured":"Everds, N.E. (2007). Chapter 5\u2014Hematology of the Laboratory Mouse. American College of Laboratory Animal Medicine, The Mouse in Biomedical Research, Academic Press. [2nd ed.]. XVII\u2013XVIII.","DOI":"10.1016\/B978-012369454-6\/50059-5"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"441","DOI":"10.5649\/jjphcs.38.441","article-title":"Gender Differences in Hematological Toxicity among Patients with Non-small Cell Lung Cancer Given Combination of Platinating Agent and Gemcita-bine","volume":"38","author":"Keira","year":"2012","journal-title":"J. Pharm. Health Care Sci."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7081\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:14:27Z","timestamp":1760033667000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/26\/15\/7081"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,23]]},"references-count":51,"journal-issue":{"issue":"15","published-online":{"date-parts":[[2025,8]]}},"alternative-id":["ijms26157081"],"URL":"https:\/\/doi.org\/10.3390\/ijms26157081","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,23]]}}}